More about

Dermatitis

News
November 16, 2022
2 min read
Save

Dupilumab levels may be unrelated to treatment response, safety in atopic dermatitis

Dupilumab levels may be unrelated to treatment response, safety in atopic dermatitis

Serum dupilumab levels showed no correlation to treatment response or adverse events in patients with atopic dermatitis during the first year of treatment, according to a study.

News
November 08, 2022
1 min read
Save

Vtama safe, effective with minimal systemic exposure in children with atopic dermatitis

Vtama safe, effective with minimal systemic exposure in children with atopic dermatitis

Dermavant Sciences announced positive results from its maximal usage study of Vtama cream in the treatment of atopic dermatitis for children aged as young as 2 years, according to a company press release.

News
November 08, 2022
1 min read
Save

Safety data show Adbry well tolerated in treatment of moderate to severe atopic dermatitis

Safety data show Adbry well tolerated in treatment of moderate to severe atopic dermatitis

The results of pooled safety data for Adbry showed positive effects in the prolonged treatment of moderate to severe atopic dermatitis, according to a study.

News
October 28, 2022
2 min read
Save

Novel topical complex derived from spinach shows efficacy in atopic dermatitis

Novel topical complex derived from spinach shows efficacy in atopic dermatitis

A novel investigational compound derived from baby spinach leaves yielded improvements in efficacy with an attractive safety profile in adults with atopic dermatitis, according to a study.

News
October 24, 2022
3 min read
Save

Global understanding: Atopic dermatitis awareness campaign supports people around world

Global understanding: Atopic dermatitis awareness campaign supports people around world

LEO Pharma has partnered with eczema patient advocate Ashley Ann Lora for the “AD Days Around the World” campaign, an effort to document the stories of individuals living with atopic dermatitis to help inspire others.

News
October 04, 2022
5 min read
Save

Q&A: Demodex mites may play role in rosacea development

Q&amp;A: <i>Demodex</i> mites may play role in rosacea development

Researchers have long questioned whether the microscopic Demodex mite is a cause or effect of rosacea, a skin condition affecting 16 million Americans.

News
September 12, 2022
1 min read
Save

Head, neck dermatitis improved with rocatinlimab

Head, neck dermatitis improved with rocatinlimab

MILAN — Patients with atopic dermatitis of the head and neck who did not have success with topical therapy experienced greater improvement with rocatinlimab treatment.

News
September 09, 2022
1 min read
Save

Lower disease severity associated with better quality of life in dermatitis

Lower disease severity associated with better quality of life in dermatitis

MILAN — Atopic dermatitis patients with lower disease severity and better quality of life also were associated with lower clinical burdens and work impairment, according to a poster presented at the European Academy of Dermatology and Venereology Congress.

News
May 17, 2022
1 min read
Save

Baracitinib news tops AAD Annual Meeting coverage

Healio was on site at this year’s American Academy of Dermatology Annual Meeting, covering a range of important dermatology news, including updates to atopic dermatitis, psoriasis and hair disorders.

News
January 14, 2022
1 min read
Save

FDA approves Rinvoq for atopic dermatitis

FDA approves Rinvoq for atopic dermatitis

The FDA approved Rinvoq, a selective JAK inhibitor, for the treatment of moderate to severe atopic dermatitis among patients aged 12 years and older, according to a press release.

View more